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R985DispatchesAnesthetic Mechanisms: Worms Light the WayIn the nematode C. elegans, immobility induced by the anesthetic halothane is
coupled to its ability to modulate neuronal resting membrane potential,
perhaps through effects on leak channels; a similar anesthetic, isoflurane,
appears to work a different way.Roderic G. Eckenhoff
Anesthetic drugs have been
considered one of the most
important medical advances of all time,
and are used in about 240 million
surgical cases every year across the
world [1]. Although anesthetics have
now reached the stage of being
standard-of-care, are apparently safe
and are essentially taken-for-granted,
we do not yet know how or why the
drugs produce the state of anesthesia,
a term coined by Oliver Wendell
Holmes in 1846. Early theories
focused on the lipid bilayer as
the primary target, buoyed by the
strong correlation between
hydrophobicity and anesthetic
potency (the Overton-Meyer
relationship). However, a host of
inconsistencies shifted investigators’
attentions to other macromolecular
targets. The finding that inhibition
of the activity of a lipid-free enzyme,
firefly luciferase, could mimic the
Overton-Meyer relationship put
proteins squarely in the spotlight [2],
and lipid-based ideas have
subsequently dwindled (perhaps
prematurely). Of course, the
proteome is large, and the very
fact that a firefly enzyme of little
human or neuronal relevance
can satisfy the Overton-Meyer
relationship so well suggests that
finding the truly important targets
might be akin to the proverbial needle
in the haystack.
But progress has been made.
A wide variety of ion channels and
neurotransmitter receptors have
been implicated to various degrees [3],
but none has emerged as being
both necessary and sufficient [4].
Combining thiswith the knowledge that
all organisms can be anesthetized
within a fairly narrow range of
anesthetic concentrations, the fact
that resistance is uncommon, and
that antagonists do not exist, leadsone to suspect that the anesthetic
target is more process than protein,
or that the critical protein is
exceptionally well-conserved. Given
that an exceptionally conserved
target underlying anesthesia is likely
to have been identified by now,
we seem stuck with the idea that
a process consisting of several,
or even many, proteins underlies
anesthetic action. The paper in
this issue of Current Biology
by Singaram et al. [5] challenges
this idea.
Singaram et al. [5] took advantage of
recent developments in optogenetics
[6] to test the hypothesis that
modulation of the resting membrane
potential controls the anesthetic state.
The idea is that resting membrane
potential is lowered via effects, direct
or indirect, of these small drugs on
specific ion channels, making typical
depolarizing events less effective in
propagating signals. The authors
used the tiny transparent nematode
Caenorhabditis elegans as a model,
having previously established its
validity for anesthetic mechanism
research [7]. These small metazoans
constantly move in search of food,
and respond to touch or light by
altering their course and speed. Thus,
their mobility, either spontaneous
or elicited, serves as a useful and
robust anesthetic endpoint — much
the same as it does in humans. The
authors have shown that the wild-type
nematode responds to a wide range
of anesthetics in an Overton-Meyer
manner at concentrations within
an order of magnitude of those
producing the same endpoint
in mammals [8].
Singaram et al. [5] generated worms
expressing channelrhodopsin-2,
an ion channel causing depolarization
when activated by light, in cholinergic
neurons, and found that they could
optically reverse the immobilizing
effect of the volatile anesthetichalothane (Figure 1). Activation
of halorhodopsin expressed in
the same neurons, a channel that
produces hyperpolarization,
dramatically increased the sensitivity
of the nematode to halothane. These
manipulations of the resting membrane
potential alter halothane sensitivity
by about 25-fold, an unprecedented
magnitude given that the population
variance, as reflected by Hill
coefficients of 20 or more, is
exceedingly small. For example, prior
genetic or pharmacological
manipulations rarely produced mobility
effects exceeding two-fold.
Finally, Singaram et al. [5] went
a step further to implicate the
resting membrane potential by
introducing either loss-of-function or
gain-of-function mutations into ion
channels known to modulate the
resting membrane potential. In each
case, the predicted result was
obtained. It is important to point out,
however, that this does not necessarily
implicate these ion channels as direct
targets for halothane. There are a host
of possible targets that can have
effects on the resting membrane
potential, and it has been estimated
that halothane can interact specifically
with as much as 15% of the proteome
[9]. So far, this all seems consistent
with the notion that the anesthetic
target is a process, the resting
membrane potential.
But this also leads to the obvious
criticism that the resting membrane
potential itself may not be the
modulated process, but rather an
orthogonal or opposed process.
Singaram et al. [5] anticipated this
by examining another anesthetic,
isoflurane (physicochemically very
similar to halothane). Remarkably,
they found that isoflurane sensitivity
is unaltered by the same treatments.
This same group has long suggested
that targets might be different for
even these small, promiscuous
volatile anesthetics [10], but this is
a startling confirmation that targets
could be fundamentally different; one
ormore targets can actually distinguish
halothane from isoflurane, moving us
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Figure 1. Differential anesthetic effects.
A few overlapping processes that might lead to the immobility endpoint. The Singaram et al. [5]
study suggests that halothane immobility is transduced dominantly via the resting membrane
potential (resting membrane potential; thick blue arrow), although prior work shows that halo-
thane also affects targets like synaptic receptors and machinery that underlie the other two
processes (thin blue arrows). As the results of Singaram et al. [5] also indicate that isoflurane
does not achieve immobility via resting membrane potential, even though it acts on many of
the same ion channels as halothane (for example, tandem-pore K-channels, tonic GABA
receptors), its dominant pathway for achieving immobility might be via synaptic receptors
(thick green arrow) — or perhaps through synaptic machinery, mitochondria or direct muscle
effects (excitation-contraction, EC, coupling). Thus, similar in vitro effects may not translate to
similar in vivo effects.
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Ion channels with this degree of
selectivity have not yet emerged, and
the only high resolution complexes in
the Protein Database (http://www.rcsb.
org/pdb) show that isoflurane and
halothane occupy the same protein
binding sites with comparable, and
relatively high, affinity [11].
What targets then? One possibility
might be within the large family of
G-protein-coupled receptors.
The largest subgroup of these
receptors, those underlying olfaction,
have evolved to detect and distinguish
small volatile molecules from each
other, and any anesthesiologist
knows that halothane and isoflurane
smell different! In fact, previous
work has shown that individual
olfactory receptors can distinguish
halothane from isoflurane from
sevoflurane [12]. Finally, these
receptors are not just expressed
in the nose — some are found in the
brain and spinal cord — suggesting
that they might serve an internal
chemical sensing role, in addition
to their more familiar external role.
Finding such a target should be
of high priority, as this sort of
selectivity argues strongly that
necessary and sufficient targets
might exist and, more importantly,
that further anesthetic drug
optimization can occur.As an aside, this paper [5] should be
of general interest to experimental
biologists. Anesthetic drugs are clearly
not non-specific enough tobe ignored in
experimental models. Their required
(and justified) use in animals tominimize
pain and suffering may contaminate
data in unpredictable ways. But,
because this study suggests not all
anesthetics act alike, additional controls
with other anesthetics should allow
agreaterdegreeof confidence in results.
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Advice from PiranhasAn elegant new study has correlated the generation of sound patterns in the
red-bellied piranha (Pygocentrus nattereri) with three distinct behaviours.Edda Kastenhuber
and Stephan C.F. Neuhauss
The proverb that barking dogs never
bite might be true for the mammalian
species but clearly not for the
red-bellied piranha Pygocentrusnattereri, which is justifiably dreaded
for its flesh-shearing bites. This
carnivorous fish inhabits the wild rivers
of South America and might be best
known for its unique, sharp rows of
teeth and bloody-minded craving for
meat, which perhaps explains why only
